Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 30S ribosomal subunit decoding A-site is a highly conserved region within the bacterial ribosome that serves as the primary checkpoint for ensuring the accuracy of protein synthesis [1]. Located within the 16S ribosomal RNA (rRNA), the A-site (aminoacyl site) facilitates the critical interaction between the mRNA codon and the incoming aminoacyl-tRNA anticodon [2]. During successful decoding, specific adenine residues (A1492 and A1493) flip out of the rRNA helix to monitor the geometry of the codon-anticodon minor groove, a process essential for discriminating between correct and incorrect tRNA matches [2]. This site is a major pharmacological target for several classes of antibiotics, most notably aminoglycosides and tetracyclines [3]. Aminoglycosides bind to the A-site and lock it in a 'closed' conformation, which forces the ribosome to accept mismatched tRNAs, resulting in the production of toxic, misfolded proteins that lead to bacterial cell death [1, 5]. Tetracyclines, conversely, physically occupy the A-site to prevent tRNA entry, thereby inhibiting protein elongation and exerting a bacteriostatic effect [5]. While highly effective against a broad spectrum of bacterial infections, drugs targeting this site can cause significant side effects, such as nephrotoxicity and ototoxicity, due to structural similarities between bacterial and human mitochondrial ribosomes [3, 4].
Aminoglycosides bind to the 16S rRNA A-site, inducing a conformational change (flipping of A1492 and A1493) that stabilizes near-cognate tRNA binding, leading to mistranslation and protein misfolding. Tetracyclines sterically block the A-site, preventing the docking of aminoacyl-tRNA and halting polypeptide elongation.
13 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 30S ribosomal subunit decoding A-site (30S A-site).